Citations

Citations to this article as recorded by  

• Comparative short-term efficacy of upadacitinib versus tofacitinib for ulcerative colitis: a 24-week real-world study in Japan
  Akiko Tamura, Hiromichi Shimizu, Toshimitsu Fujii, Ami Kawamoto, Ryo Morikawa, Shuji Hibiya, Kento Takenaka, Masakazu Nagahori, Kazuo Ohtsuka, Ryuichi Okamoto
  Intestinal Research.2026; 24(1): 95.     CrossRef
• Tofacitinib safety in inflammatory bowel disease: a disproportionality analysis of the FDA adverse event reporting system
  Suqi Zeng, Sihan Zhang, Jianxuan Sun, Junjie Chen
  Naunyn-Schmiedeberg's Archives of Pharmacology.2026;[Epub]     CrossRef
• Inflammatory bowel disease therapeutics: a bibliometric analysis of tofacitinib research in ulcerative colitis
  Jianping Zhou, Yuting Xi, Yaping Zhang, Rui Zhang, Hao Fu, Ce Zhou
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Association between inflammatory bowel disease, current therapies, and cardiovascular events: a review and meta-analysis of data from 2.2 million individuals
  David-Raj Thomas, Gavin Huangfu, Fiona Yeaman, Sara Sukudom, Nick S R Lan, Girish Dwivedi, Lena Thin
  Journal of Crohn's and Colitis.2025;[Epub]     CrossRef
• Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel Disease
  Anja Bizjak, Boris Gole, Gregor Jezernik, Uroš Potočnik, Mario Gorenjak
  Genes.2025; 16(8): 908.     CrossRef
• Histological healing induced by tofacitinib in ulcerative colitis: A multicentre study
  Sophie Vieujean, David Laharie, Anthony Buisson, Xavier Roblin, Mathurin Fumery, Stephane Nancey, Pauline Wils, Romain Altwegg, Laurence Seidel, Bénédicte Caron, Laurent Peyrin-Biroulet
  Digestive and Liver Disease.2024; 56(4): 613.     CrossRef
• Continued JAK inhibitor treatment on the risk of recurrent herpes zoster reactivation in patients with immune-mediated inflammatory diseases: A nationwide population-based study in South Korea
  Young-Eun Kim, Ye-Jee Kim, Dae Hyun Jeong, Seonok Kim, Min Jee Kim, Hyeon Hwa Kim, Kyung-Wook Jo, Sang Hyoung Park, Seokchan Hong
  Seminars in Arthritis and Rheumatism.2024; 65: 152362.     CrossRef
• Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus
  Pablo A. Olivera, Axel Dignass, Marla C. Dubinsky, Giovanni Peretto, Paulo G. Kotze, Iris Dotan, Taku Kobayashi, Subrata Ghosh, Fernando Magro, Jose Rocha Faria-Neto, Britta Siegmund, Silvio Danese, Laurent Peyrin-Biroulet
  Digestive and Liver Disease.2024; 56(8): 1270.     CrossRef
• Long-term efficacy and safety of tofacitinib in patients with ulcerative colitis: 3-year results from a real-world study
  Hiromichi Shimizu, Yuko Aonuma, Shuji Hibiya, Ami Kawamoto, Kento Takenaka, Toshimitsu Fujii, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Ryuichi Okamoto
  Intestinal Research.2024; 22(3): 369.     CrossRef
• Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study
  Hyuk Yoon, Byong Duk Ye, Sang-Bum Kang, Kang-Moon Lee, Chang Hwan Choi, Joo-young Jo, Juwon Woo, Jae Hee Cheon
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Effectiveness of tofacitinib in patients with ulcerative colitis: an updated systematic review and meta-analysis of real-world studies
  Chien-Hung Lin, Wen-Sheng Liu, Chuan Wan, Hsin-Hui Wang
  BMJ Open Gastroenterology.2024; 11(1): e001347.     CrossRef
• Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
  María Chaparro, Diana Acosta, Cristina Rodríguez, Francisco Mesonero, Miren Vicuña, Manuel Barreiro-de Acosta, Agnès Fernández-Clotet, Álvaro Hernández Martínez, Maite Arroyo, Isabel Vera, Alexandra Ruiz-Cerulla, Beatriz Sicilia, M. José Cabello Tapia, Ca
  American Journal of Gastroenterology.2023; 118(7): 1237.     CrossRef
• Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
  Seung Hwan Shin, Kyunghwan Oh, Sung Noh Hong, Jungbok Lee, Shin Ju Oh, Eun Soo Kim, Soo-Young Na, Sang-Bum Kang, Seong-Joon Koh, Ki Bae Bang, Sung-Ae Jung, Sung Hoon Jung, Kyeong Ok Kim, Sang Hyoung Park, Suk-Kyun Yang, Chang Hwan Choi, Byong Duk Ye
  Therapeutic Advances in Gastroenterology.2023;[Epub]     CrossRef
• Review article: Risk of cardiovascular events in patients with inflammatory bowel disease receiving small molecule drugs
  Pablo A. Olivera, Juan S. Lasa, Giovanni Peretto, Stephane Zuily, Silvio Danese, Laurent Peyrin‐Biroulet
  Alimentary Pharmacology & Therapeutics.2023; 57(11): 1231.     CrossRef
• Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective
  Shubhra Mishra, Anuraag Jena, Rinkalben Kakadiya, Vishal Sharma, Vineet Ahuja
  Expert Review of Gastroenterology & Hepatology.2022; 16(8): 737.     CrossRef
• Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
  Kyuwon Kim, Hee Seung Hong, Kyunghwan Oh, Jae Yong Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye, Sang Hyoung Park
  The Korean Journal of Internal Medicine.2022; 37(6): 1140.     CrossRef
• Review article: guide to tofacitinib dosing in patients with ulcerative colitis
  Peter M. Irving, Yvette Leung, Marla C. Dubinsky
  Alimentary Pharmacology & Therapeutics.2022; 56(7): 1131.     CrossRef
• Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs
  Soo-Young Na, You Sun Kim
  The Korean Journal of Internal Medicine.2022; 37(5): 906.     CrossRef
• Effectiveness and Safety of Tofacitinib for Ulcerative Colitis
  Vikas Taneja, Mohammed El-Dallal, Zadid Haq, Kartikeya Tripathi, Hannah K. Systrom, Linda F. Wang, Hyder Said, Paul A. Bain, Youlian Zhou, Joseph D. Feuerstein
  Journal of Clinical Gastroenterology.2022; 56(10): e323.     CrossRef
• Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis
  Laura A. Lucaciu, Nathan Constantine-Cooke, Nikolas Plevris, Spyros Siakavellas, Lauranne A.A.P. Derikx, Gareth-Rhys Jones, Charles W. Lees
  Therapeutic Advances in Gastroenterology.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases
  Muhammad Zubair, Fatma A. Abouelnazar, Muhammad Asad Iqbal, Jingyun Pan, Xuwen Zheng, Tao Chen, Wenming Shen, Jinnan Yin, Yongmin Yan, Pengjun Liu, Fei Mao, Ying Chu
  Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
• Myths and Realities about the Private Sector Stem Cell Industry in Malaysia
  Kean Chang Phang, Mohammad Firdaus Bin Abdul Aziz
  Asian Bioethics Review.2025; 17(4): 729.     CrossRef
• Optimizing Wnt activation in fetal calf serum (FCS)-free organoid expansion media
  Esther J. M. Liefting, Jeffrey J. Bajramovic
  Frontiers in Toxicology.2025;[Epub]     CrossRef
• From bench to bedside: the role of gastrointestinal stem cells in health and disease
  Xiaopeng Bai, Eikichi Ihara, Yoshimasa Tanaka, Yosuke Minoda, Masafumi Wada, Yoshitaka Hata, Mitsuru Esaki, Haruei Ogino, Takatoshi Chinen, Yoshihiro Ogawa
  Inflammation and Regeneration.2025;[Epub]     CrossRef
• Cell-derived vesicles extruded from adipose mesenchymal stem cells attenuate intestinal inflammation and augment epithelial regeneration in a colitis model
  Min Kyoung Jo, Hyeon-Jeong Jeon, So Hui Kim, Hye Sun Lee, Seong-Eun Kim, Sung-Ae Jung, Hui-Chong Lau, Sung-Soo Park, Seung Wook Oh, Chang Mo Moon
  Nanoscale.2025; 17(47): 27337.     CrossRef
• The nasal basal cell population shifts toward a diseased phenotype with impaired barrier formation capacity in allergic rhinitis
  Emma Ruysseveldt, Brecht Steelant, Tine Wils, Jonathan Cremer, Dominique M.A. Bullens, Peter W. Hellings, Katleen Martens
  Journal of Allergy and Clinical Immunology.2024; 154(3): 631.     CrossRef
• Cellular Plasticity in Gut and Liver Regeneration
  Minwook Kim, Yoojeong Park, You Sun Kim, Sungjin Ko
  Gut and Liver.2024; 18(6): 949.     CrossRef
• Revolutionizing medicine: recent developments and future prospects in stem-cell therapy
  Bashdar M. Hussen, Mohammad Taheri, Raya Kh. Yashooa, Gaylany H. Abdullah, Snur R. Abdullah, Ramiar Kamal Kheder, Suhad A. Mustafa
  International Journal of Surgery.2024; 110(12): 8002.     CrossRef
• Nigakinone alleviates DSS‐induced experimental colitis via regulating bile acid profile and FXR/NLRP3 signaling pathways
  Fangle Liu, Yufeng Yao, Qian Wang, Fengxue Zhang, Meiqi Wang, Chenchen Zhu, Chaozhan Lin
  Phytotherapy Research.2023; 37(1): 15.     CrossRef
• TNFα Induces LGR5+ Stem Cell Dysfunction In Patients With Crohn’s Disease
  Chansu Lee, Minae An, Je-Gun Joung, Woong-Yang Park, Dong Kyung Chang, Young-Ho Kim, Sung Noh Hong
  Cellular and Molecular Gastroenterology and Hepatology.2022; 13(3): 789.     CrossRef
• Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress
  Geonhee Han, Haeun Cho, Hyosuk Kim, Yeongji Jang, Hochung Jang, Da Eun Kim, Eun Sun Kim, Eun Hye Kim, Kwang Yeon Hwang, Kwangmeyung Kim, Yoosoo Yang, Sun Hwa Kim
  Biomaterials Science.2022; 10(8): 2076.     CrossRef
• The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer
  Gang Guo, Zhaobang Tan, Yaping Liu, Feiyu Shi, Junjun She
  Stem Cell Research & Therapy.2022;[Epub]     CrossRef
• Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
  Zhengping Che, Ziyu Ye, Xueying Zhang, Bihua Lin, Weiqing Yang, Yanfang Liang, Jincheng Zeng
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Mechanotransduction through adhesion molecules: Emerging roles in regulating the stem cell niche
  Ryan Lim, Avinanda Banerjee, Ritusree Biswas, Anana Nandakumar Chari, Srikala Raghavan
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• Clinical applications and optimization of patient-derived organoids in intestinal diseases
  Tae Il Kim
  Organoid.2022; 2: e22.     CrossRef
• Effects of human induced pluripotent stem cell-derived intestinal organoids on colitis-model mice
  Anna Nakanishi, Satoshi Toyama, Daichi Onozato, Chihiro Watanabe, Tadahiro Hashita, Takahiro Iwao, Tamihide Matsunaga
  Regenerative Therapy.2022; 21: 351.     CrossRef
• Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
  Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding, Sepideh Afshar
  International Journal of Molecular Sciences.2021; 22(6): 2805.     CrossRef
• Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn’s disease: a retrospective observational stud
  Min Young Park, Yong Sik Yoon, Jong Lyul Lee, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Chang Sik Yu
  Stem Cell Research & Therapy.2021;[Epub]     CrossRef
• Current Trends and Research Topics Regarding Intestinal Organoids: An Overview Based on Bibliometrics
  Meng-Meng Zhang, Ke-Lu Yang, Yan-Cheng Cui, Yu-Shi Zhou, Hao-Ran Zhang, Quan Wang, Ying-Jiang Ye, Shan Wang, Ke-Wei Jiang
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• The Potential of Vitamin D3 to Repaired Mucosal Injury in Dextran Sulfate Sodium Induced Acute Colitis in Mice
  Satrio Wibowo, Krisni Subandiyah, Kusworini Handono, Sri Poeranto
  Open Access Macedonian Journal of Medical Sciences.2021; 9(B): 931.     CrossRef
• Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review
  Ji Young Chang, Jae Hee Cheon
  Precision and Future Medicine.2021; 5(4): 151.     CrossRef
• Mutual regulation between butyrate and hypoxia‐inducible factor‐1α in epithelial cell promotes expression of tight junction proteins
  Jiuheng Yin, Chao Zhou, Kunqiu Yang, Yanbei Ren, Yuan Qiu, Pengyuan Xu, Weidong Xiao, Hua Yang
  Cell Biology International.2020; 44(6): 1405.     CrossRef
• Letter: off‐label use of hyperbaric oxygen therapy in inflammatory bowel disease—Authors’ reply
  Melek Simsek, Nanne K. H. de Boer
  Alimentary Pharmacology & Therapeutics.2020; 52(1): 216.     CrossRef
• The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy
  Agata Binienda, Sylwia Ziolkowska, Ingvild H. Hauge, Maciej Salaga
  Current Drug Targets.2020; 21(14): 1405.     CrossRef